We then assessed the efficacy of protein-unconjugated liposomes loaded with Red-DEVD and discovered that administering 300–900 ng of Red-DEVD via unconjugated liposomes significantly alleviated the elevations in circulating ALT and thrombocytopenia in TAA-challenged mice (average mouse weight 28 g; Figure 9B,C). The gene discussed is GPT; the disease is Thrombocytopenia.